Status:

UNKNOWN

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Lead Sponsor:

University Hospital, Caen

Conditions:

Malignant Mesothelioma

Metastatic Cancer

Eligibility:

All Genders

Brief Summary

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers related to cancer....

Detailed Description

OBJECTIVES: Primary * Determine if mesothelin and osteopontin in serum can serve as early markers of malignant transformation into mesothelioma. Secondary * Determine if there are cytological, his...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Inclusion criteria:
  • Diagnosis of mesothelial hyperplasia and meeting 1 of the following criteria:
  • Confirmed prior exposure to asbestos and presence of pleural effusion and meets 1 of the following diagnostic criteria:
  • Mesothelioma
  • Mesothelial hyperplasia of unspecified malignancy
  • Reactional inflammatory hyperplasia
  • No asbestos exposure but pleural effusion with pleural malignant mesothelioma or pulmonary metastasis
  • Prior exposure to asbestos, no pleural effusion, and asymptomatic (pleural plaques present)
  • No prior exposure to asbestos but with benign pleural effusion
  • Tissue obtained by pleuroscopy, surgical biopsy, or video-thoracoscopy available
  • Paraffin-embedded and frozen tissue available
  • Exclusion criteria:
  • Solitary fibrous tumor
  • Diffuse pleural fibrosis
  • Purulent pleurisy
  • PATIENT CHARACTERISTICS:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • No prior chemotherapy or radiotherapy

Exclusion

    Key Trial Info

    Start Date :

    April 1 2007

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    270 Patients enrolled

    Trial Details

    Trial ID

    NCT00899613

    Start Date

    April 1 2007

    Last Update

    December 15 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    CHU de Caen

    Caen, France, 14033